NCT06263673View on ClinicalTrials.gov

Anti-Diabetic Medications to Fight PD and LBD

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

January 8, 2025

Study Completion Date

December 31, 2025

Conditions
Lewy Body DementiaParkinson Disease
Interventions
DRUG

Sitagliptin

100 mg once daily, oral

DRUG

Dapagliflozin

10 mg once daily, oral

DRUG

Placebo

Once daily, oral. Looks similar to the study drug, but it contains no active ingredient.

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER